These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4941908)

  • 1. Median eminence lesions and serum prolactin: influence of ovariectomy and ergocornine.
    Welsch CW; Squiers MD; Cassell E; Chen CL; Meites J
    Am J Physiol; 1971 Dec; 221(6):1714-7. PubMed ID: 4941908
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct inhibition by ergocornine of pituitary prolactin release.
    Lu KH; Koch Y; Meites J
    Endocrinology; 1971 Jul; 89(1):229-33. PubMed ID: 5089657
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of prolactin and ergot alkaloids on the tubero-infundibular dopamine (DA) neurons.
    Hökfelt T; Fuxe K
    Neuroendocrinology; 1972; 9(2):100-22. PubMed ID: 5061810
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of ergocornine on prolactin secretion by hypophysial homografts.
    Malven PV; Hoge WR
    Endocrinology; 1971 Feb; 88(2):445-9. PubMed ID: 5540057
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum prolactin levels in rats with pituitary transplants or hypothalamic lesions.
    Chen CL; Amenomori Y; Lu KH; Voogt JL; Meites J
    Neuroendocrinology; 1970; 6(4):220-7. PubMed ID: 5473372
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct inhibition of pituitary LH secretion in rats by CB-154 (2-Br-alpha-ergocryptine).
    Seki M; Seki K; Yoshihara T; Watanabe N; Okumura T
    Endocrinology; 1974 Mar; 94(3):911-4. PubMed ID: 4591828
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibition of prolactin secretion by ergocornine and 2-Br-alpha-ergocryptine: direct action on the hypophysis in culture].
    Pasteels JL; Danguy A; Frérotte M; Ectors F
    Ann Endocrinol (Paris); 1971; 32(1):188-92. PubMed ID: 5556257
    [No Abstract]   [Full Text] [Related]  

  • 8. Relation of prolactin and estrogen to mammary tumorigenesis in the rat.
    Meites J
    J Natl Cancer Inst; 1972 Apr; 48(4):1217-24. PubMed ID: 5023679
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of median eminence (ME) lesions on plasma levels of FSH, LH, and prolactin in the rat.
    Bishop W; Krulich L; Fawcett CP; McCann SM
    Proc Soc Exp Biol Med; 1971 Mar; 136(3):925-7. PubMed ID: 5555390
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of ergot alkaloids on pituitary prolactin and prolactin-dependent processes.
    Floss HG; Cassady JM; Robbers JE
    J Pharm Sci; 1973 May; 62(5):699-715. PubMed ID: 4574586
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of hypothalamic and preoptic electrochemical stimulation on gonadotropin and prolactin release in proestrous rats.
    Kalra SP; Ajika K; Krulich L; Fawcett CP; Quijada M; McCann SM
    Endocrinology; 1971 May; 88(5):1150-8. PubMed ID: 4926246
    [No Abstract]   [Full Text] [Related]  

  • 12. DNA synthesis and the secretion of prolactin and growth hormone by the pituitary gland of the male rat: effects of diethylstilboestrol and 2-bromo-alpha-ergocryptine methanesluphonate.
    Davies C; Jacobi J; Lloyd HM; Meares JD
    J Endocrinol; 1974 Jun; 61(3):411-7. PubMed ID: 4366118
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sensitivity of the anterior hypothalamus to progesterone and to medroxyprogesterone].
    Pasteels JL; Ectors F
    Ann Endocrinol (Paris); 1968; 29(5):663-78. PubMed ID: 4881134
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of thyrotropin and prolactin secretions in primary hypothyroidism by 2-Br-alpha-ergocryptine.
    Miyal K; Onishi T; Hosokawa M; Ishibashi K; Kumahara Y
    J Clin Endocrinol Metab; 1974 Aug; 39(2):391-4. PubMed ID: 4418165
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of pituitary prolactin secretion by human placental lactogen in rats.
    Nagasawa H; Yanai R; Yamanouchi K
    J Endocrinol; 1976 Oct; 71(1):115-20. PubMed ID: 10338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lactation and prolactin secretion in rats by ergot alkaloids.
    Shaar CJ; Clemens JA
    Endocrinology; 1972 Jan; 90(1):285-8. PubMed ID: 5009064
    [No Abstract]   [Full Text] [Related]  

  • 17. Total blockade of phasic pituitary prolactin release in rats: effect on serum LH and progesterone during the estrous cycle and pregnancy.
    Döhler KD; Wuttke W
    Endocrinology; 1974 Jun; 94(6):1595-600. PubMed ID: 4831125
    [No Abstract]   [Full Text] [Related]  

  • 18. Pituitary GH and hypothalamic GHRF after median eminence implantation of ovine or human GH.
    Voogt JL; Clemens JA; Negro-Vilar A; Welsch C; Meites J
    Endocrinology; 1971 Jun; 88(6):1363-7. PubMed ID: 4929558
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of ergocornine and ergocryptine on growth of 7,12-dimethylbenzanthracene-induced mammary tumors in rats.
    Cassell EE; Meites J; Welsch CW
    Cancer Res; 1971 Jul; 31(7):1051-3. PubMed ID: 5560385
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of ergot drugs on prolactin and growth hormone secretion, and on mammary nucleic acid content in C3H-Bi mice.
    Sinha YN; Selby FW; VanderLaan WP
    J Natl Cancer Inst; 1974 Jan; 52(1):189-91. PubMed ID: 4810962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.